MSF seek a clinical trial Co-PI & Site Lead MDR TB (Karakalpakstan)
13 January 2016
Médecins Sans Frontières is setting up a Pragmatic Clinical Trial for a more Effective, Concise And Less toxic MDR-TB treatment regimen (TB PRACTECAL). It is a randomised, controlled, open label phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug resistant tuberculosis.
To lead this trial MSF is offering and exciting and challenging position for a Clinical Trial Co-Principal Investigator to function as the Clinical Trial Site Lead for the TB PRACTECAL clinical trials to be conducted in Karakalpakstan, Uzbekistan.
The MSF Clinical Trial Site Lead (Co-PI) will take responsibility for the good conduct of the TB PRACTECAL Clinical Trial in close collaboration with the Ministry of Health Principal Investigator and with MSF and Ministry of Health Project teams on site.
Please see the job advertisement and job description for full details.
- Closing date for applications: 21 February (inclusive), applications will be reviewed upon reception and interviews organised accordingly, the position may be offered before the deadline as soon as a suitable candidate is found.
- Interviews: by appointment, only shortlisted candidates will be contacted for an interview
- Starting date: March 2016, or sooner